Committee Opinion No 712 Intrapartum Management.58
Committee Opinion No 712 Intrapartum Management.58
Committee Opinion No 712 Intrapartum Management.58
Puopolo, MD, PhD; Richard Beigi, MD; Neil S. Silverman, MD; and Yasser Y. El-Sayed, MD.
e96 Committee Opinion Intrapartum Management of Intraamniotic Infection OBSTETRICS & GYNECOLOGY
VOL. 130, NO. 2, AUGUST 2017 Committee Opinion Intrapartum Management of Intraamniotic Infection e97
Postcesarean delivery : One additional dose of the chosen regimen is indicated. Add clindamycin 900 mg IV or metronidazole 500 mg IV for at
least one additional dose.
Postvaginal delivery : No additional doses required; but if given, clindamycin is not indicated.
Alternative Regimens
Postcesarean delivery : One additional dose of the chosen regimen is indicated. Additional clindamycin is not required.
Postvaginal delivery : No additional doses required, but if given, clindamycin is not indicated.
e98 Committee Opinion Intrapartum Management of Intraamniotic Infection OBSTETRICS & GYNECOLOGY
VOL. 130, NO. 2, AUGUST 2017 Committee Opinion Intrapartum Management of Intraamniotic Infection e99
e100 Committee Opinion Intrapartum Management of Intraamniotic Infection OBSTETRICS & GYNECOLOGY
VOL. 130, NO. 2, AUGUST 2017 Committee Opinion Intrapartum Management of Intraamniotic Infection e101